COSMOS Pharmaceutical Corporation (JP:3349)
:3349
Want to see JP:3349 full AI Analyst Report?
3349 Stock Chart & Stats
¥6699.00
¥109.00(1.60%)
At close: 4:00 PM EST
¥6699.00
¥109.00(1.60%)
Day’s Range― - ―
52-Week Range¥5,615.00 - ¥10,045.00
Previous CloseN/A
Volume659.40K
Average Volume (3M)399.89K
Market Cap
¥460.72B
Enterprise Value¥496.37B
Total Cash (Recent Filing)¥57.04B
Total Debt (Recent Filing)¥49.96B
Price to Earnings (P/E)14.7
Beta-0.23
Next Earnings
Jul 13, 2026EPS Estimate
117.37Next Dividend Ex-DateN/A
Dividend Yield0.93%
Share Statistics
EPS (TTM)390.85
Shares Outstanding80,001,600
10 Day Avg. Volume586,980
30 Day Avg. Volume399,893
Financial Highlights & Ratios
PEG Ratio0.85
Price to Book (P/B)2.72
Price to Sales (P/S)0.69
P/FCF Ratio-814.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)418.47
Revenue Forecast (FY)¥1.18T
Bulls Say, Bears Say
Bulls Say
Consistent Revenue Growth And Stable MarginsSustained revenue growth with stable gross and net margins indicates durable demand and effective cost control. Over 2-6 months this underpins reinvestment capacity, pricing power in retail categories, and resilience to cyclical swings, supporting long-term operating cash generation and strategic initiatives.
Solid Balance Sheet And Strong Equity RatioLow leverage and a strong equity ratio provide financial flexibility to fund store expansion, inventory investment, or absorb demand shocks. Robust ROE shows efficient capital use, enabling the company to pursue strategic opportunities without overly relying on costly external financing.
Scale In Drugstore Retail Network And Product MixA large retail footprint with prescriptions plus non-pharma categories yields recurring consumer demand and category diversification. Scale supports procurement leverage, merchandising efficiency, and cross-selling, which promote margin sustainability and predictable cash flows over the medium term.
Bears Say
Negative Free Cash Flow TrendPersistent negative free cash flow, despite strong operating cash flow, suggests capex or working capital drain limiting true cash available for debt reduction, dividends, or share buybacks. Over several months this can force reliance on external funding and constrain strategic flexibility.
Rising Total Debt Over TimeAn upward trend in total debt raises refinancing and interest-rate sensitivity, potentially increasing financial cost and reducing cushion for investments. If the trend continues, it could erode the current low-leverage advantage and limit ability to pursue opportunistic growth.
Slight Decline In EBIT Margin RecentlyA recent dip in EBIT margin signals rising cost pressure or competitive pricing stress. If sustained, margin compression can reduce free cash conversion and weaken returns on new stores or investments, making it harder to maintain current profitability levels over the medium term.
COSMOS Pharmaceutical Corporation News
3349 FAQ
What was COSMOS Pharmaceutical Corporation’s price range in the past 12 months?
COSMOS Pharmaceutical Corporation lowest stock price was ¥5615.00 and its highest was ¥10045.00 in the past 12 months.
What is COSMOS Pharmaceutical Corporation’s market cap?
COSMOS Pharmaceutical Corporation’s market cap is ¥460.72B.
When is COSMOS Pharmaceutical Corporation’s upcoming earnings report date?
COSMOS Pharmaceutical Corporation’s upcoming earnings report date is Jul 13, 2026 which is in 37 days.
How were COSMOS Pharmaceutical Corporation’s earnings last quarter?
COSMOS Pharmaceutical Corporation released its earnings results on Apr 13, 2026. The company reported ¥102.19 earnings per share for the quarter, beating the consensus estimate of ¥100.689 by ¥1.501.
Is COSMOS Pharmaceutical Corporation overvalued?
According to Wall Street analysts COSMOS Pharmaceutical Corporation’s price is currently Overvalued.
Does COSMOS Pharmaceutical Corporation pay dividends?
COSMOS Pharmaceutical Corporation pays a Semiannually dividend of ¥37.5 which represents an annual dividend yield of 0.93%. See more information on COSMOS Pharmaceutical Corporation dividends here
What is COSMOS Pharmaceutical Corporation’s EPS estimate?
COSMOS Pharmaceutical Corporation’s EPS estimate is 117.37.
How many shares outstanding does COSMOS Pharmaceutical Corporation have?
COSMOS Pharmaceutical Corporation has 80,001,600 shares outstanding.
What happened to COSMOS Pharmaceutical Corporation’s price movement after its last earnings report?
COSMOS Pharmaceutical Corporation reported an EPS of ¥102.19 in its last earnings report, beating expectations of ¥100.689. Following the earnings report the stock price went down -1.122%.
Which hedge fund is a major shareholder of COSMOS Pharmaceutical Corporation?
Currently, no hedge funds are holding shares in JP:3349
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. It also operates 1,130 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was founded in 1983 and is headquartered in Fukuoka, Japan.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
Create SD Holdings Co., Ltd.
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Options Prices
Currently, No data available
---